The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isNo human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
- What to watchDark urine, yellow eyes or right-sided abdominal pain.
How Cyclazodone works
A pemoline derivative — dopaminergic and noradrenergic releasing agent with a long duration and a slow onset that makes redosing tempting.
Get the structure right first, because the risk argument is entirely structural. Pemoline is 2-amino-5-phenyl-1,3-oxazol-4(5H)-one, C9H8N2O2, 176.17 Da — a five-membered oxazolidinone ring with a phenyl at C5 and an exocyclic amino group at C2.
Why a cyclopropylamine is not a neutral decoration. N-cyclopropylamines are a textbook mechanism-based inactivator motif for cytochrome P450 and for monoamine oxidase. The chemistry is specific: the enzyme abstracts a single electron from the amine nitrogen, the resulting aminium radical cation triggers ring-opening of the strained cyclopropane, and the primary carbon radical that appears alkylates whatever is nearest — the heme, or an active-site residue.
- Oral
On the goal map: Catecholamine & dopaminergic drive (Focus, memory & cognition)
Where to get Cyclazodone
When a vetted partner does, the link and code go here.
Research on Cyclazodone5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
No completed human trial
Correlative data
Community use as a stimulant. Reported experience is of strong, long-lasting focus with appetite suppression and difficulty sleeping — a conventional stimulant profile.
There is no human safety data whatsoever, which for a compound with cardiovascular-relevant stimulant activity is a more serious gap than it is for most things here.
How the mechanism reads
An N-cyclopropyl derivative of pemoline, a discontinued stimulant. It is believed to act on dopamine and noradrenaline as a releasing agent or reuptake inhibitor.
MechanisticPemoline itself was withdrawn for hepatotoxicity — idiosyncratic liver failure — and no one has established whether the cyclopropyl derivative shares that liability. That is the single most important thing about it and it is unresolved.
Mechanistic
Sources
- Gampfer TM, Klaes S, Eckstein N, Meyer MR. Toxicokinetic Studies of the Two Stimulants M-ALPHA and N-Methyl-cyclazodone Using In Vitro and In Vivo Tools. Metabolites 2026;16(5):291 · PMID 42188000
- Berkovitch M, Pope E, Phillips J, Koren G. Pemoline-associated fulminant liver failure: testing the evidence for causation. Clinical Pharmacology and Therapeutics 1995;57(6):696-698 · PMID 7781270
- Shevell M, Schreiber R. Pemoline-associated hepatic failure: a critical analysis of the literature. Pediatric Neurology 1997;16(1):14-16 · PMID 9044395
- Napoletano F, Schifano F, Corkery JM, Guirguis A, Arillotta D, Zangani C, Vento A. The Psychonauts' World of Cognitive Enhancers. Frontiers in Psychiatry 2020;11:546796 · PMID 33024436
- Vanhee C, Deconinck E, George M, Hansen A, Hackl A, Wollein U, El-Atma O, Beerbaum N, Aureli F, Borioni A, et al. The Occurrence of Illicit Smart Drugs or Nootropics in Europe and Australia and Their Associated Dangers: Results from a Market Surveillance Study by 12 Official Medicines Control Laboratories. Journal of Xenobiotics 2025;15(3):88 · PMID 40558871
- Cohen PA, Avula B, Wang YH, Zakharevich I, Khan I. Five Unapproved Drugs Found in Cognitive Enhancement Supplements. Neurology: Clinical Practice 2021;11(3):e303-e307 · PMID 34484905
Cyclazodone safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Liver disease, because its parent pemoline was withdrawn for fulminant liver failure.
- Heavy alcohol use, which compounds liver strain.
- Arrhythmia, heart disease or high blood pressure.
- Psychosis or a bipolar history.
- Taking other stimulants or an MAO inhibitor.
What’s expected
- Long-lasting stimulation with a slow onset that tempts repeat use.
- Reduced appetite and trouble falling asleep.
- Raised pulse and blood pressure.
Watch for
- Dark urine, yellow eyes or right-sided abdominal pain.
- Chest pain or a pounding pulse.
- Several nights without sleep.
Labs that tell you it’s working
- Comprehensive Metabolic Panel: ALT, AST and bilirubin catch the pemoline-type liver injury early.
- Prolactin: dopamine release suppresses it, so a low value shows the stimulant landed.
- High-Sensitivity Troponin T: cardiac strain from sustained catecholamine drive.
Pemoline derivative acting as a long-lasting dopamine and noradrenaline releaser; the unquantified risk is hepatotoxicity inherited from the parent. PMID 7781270 PMID 9044395
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Cyclazodone FAQ4 common questions
- Is Cyclazodone approved for human use?
- No. Cyclazodone is a research compound. No completed randomized human trial has given it yet.
- What is Cyclazodone researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Prolactin; High-Sensitivity Troponin T: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Cyclazodone: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



